Stocks to sell

The AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF’s year-to-date performance has been the increased popularity of high-beta securities. Moreover, many anticipate that marijuana will soon be downgraded to a Schedule II category substance from its current Schedule I status,
0 Comments
Dividend investing has proved to be among the most successful ways to accumulate wealth on Wall Street. Buying dividend stocks that grow their payout produces returns far above what non-dividend-paying stocks generate. Yet you should only buy those companies that can support their dividends. Southern Copper (NYSE:SCCO) just announced it was slashing its payout 20%.
0 Comments
February means Valentine’s Day and romance. But if you’re stubbornly holding F-rated stocks to sell in your portfolio, you’re just setting yourself up for heartbreak. The stock market is off to a solid start this year, with the Dow Jones Industrial Average up 2%, the S&P 500 index up nearly 5%, and the tech-heavy Nasdaq
0 Comments
2024 might be the year space stocks break through years of shakiness and pre-revenue indecision. Already, we’re seeing major companies like SpaceX, Rocket Lab USA (NASDAQ:RKLB), and AST SpaceMobile (NASDAQ:ASTS) rack up win after win. We’re even seeing companies like Amazon (NASDAQ:AMZN) enter the space race through its Kuiper Systems initiative. But, though space stocks
0 Comments
Growth stocks are the best investments for people pursuing maximum long-term returns. These equities can outperform the stock market and reward long-term investors. However, assets within this category can also lose significant capital for their investors or stay flat while the market surges. Periodically reviewing your portfolio and assessing your options can help you avoid being
0 Comments
The unpredictable nature of the biotech industry, which frequently flirts with failure, underscores the inherent risks and rewards associated with doomed biotech stocks. The journey from drug discovery to market approval is notoriously long and uncertain. The road often exceeds a decade, with the approval process varying significantly by drug type. This complexity, coupled with
0 Comments
The Senate Judiciary Committee’s recent hearing has intensified the scrutiny on social media giants, including Meta Platforms (NASDAQ:META) and TikTok, painting a grim reality of the platforms’ impacts on youth. As the legislative hammer looms with potential regulations, the sentiment to dispose of social media stocks to sell grows. With heart-wrenching accounts from parents whose children fell
0 Comments
If you’re invested in electric vehicle (EV) battery technology company QuantumScape (NYSE:QS), you’ll definitely want to mark your calendar. There’s a major event coming very soon, and depending on the outcome, it could change the QS stock forecast dramatically. So, unless you’re just a gambler, there’s no need to take a huge risk and buy QuantumScape shares
0 Comments
The cybersecurity market has been booming in recent years as more enterprises adopt digital transformation initiatives to enhance their productivity and efficiency. Increased digital transformation has led to increased cyber threats and data breaches. As a result, cybersecurity is essential to protect the infrastructure that supports the digital transformation efforts of modern enterprises. However, the
0 Comments